herb · for joint pain
Curcumin
Damps down the inflammation inside the joint. In trials it matched anti-inflammatory drugs without the stomach trouble.
Say that in clinical terms
Curcumin inhibits NF-kB, COX-2, LOX, and iNOS inflammatory pathways while downregulating TNF-alpha, IL-1beta, and IL-6 in synovial tissue. It is comparable to NSAIDs for OA pain without GI side effects.
How strong is the research?
6 papers read, 6 supporting.
Tested as: curcumin extract (standardized; specific bioavailability-enhancement approach and curcuminoid concentration not uniformly stated across included trials)
Who was studied: Knee and hip osteoarthritis patients across 8 trials. Other kinds of joint pain were not tested.
How much to take
daily (bioavailability-enhanced form)
500–1000 mg
Use Meriva, Longvida, CurcuWIN, or BCM-95 for 10-30x better absorption. Take with fat. Allow 4-8 weeks for full anti-inflammatory effect.
Before you take it
- No NIH ODS Tolerable Upper Intake Level (UL) established for curcumin; GI distress (nausea, diarrhea, abdominal cramping) reported in clinical trials at doses above 3-4 g/day
- Inhibits CYP3A4 and CYP2C9 enzymes in vitro; potential pharmacokinetic interactions with warfarin, statins, calcium channel blockers, and other CYP-metabolized drugs; clinical significance is higher with enhanced-bioavailability formulations (e.g., Meriva, BCM-95, Longvida, CurcuWIN) than with standard curcumin extract
- Additive antiplatelet and anticoagulant effect; concurrent use with warfarin, clopidogrel, high-dose aspirin, or other antiplatelet agents carries compounded bleeding risk
- Therapeutic supplement doses not recommended during pregnancy due to historical uterotonic use and absence of adequate safety data at doses above food-seasoning amounts
- May reduce non-heme iron absorption when taken with iron-rich meals or iron supplements; relevant for individuals with iron-deficiency anemia or at risk of deficiency
- Patients managing joint pain frequently self-medicate with NSAIDs or aspirin; curcumin's additive antiplatelet effect creates compounded bleeding risk that is especially relevant in this specific symptom context
When to take it
Best taken: with food
What we make of it
A legitimate pooled analysis of 8 trials, though our participant count is wrong.
The detail
The analysis is real, properly cited and covers 8 randomised trials. The sample size we recorded is overstated — the actual total is smaller.